BAŞARAN, G. Et Al. 2008. Benefit from adjuvant anthracyclines according to hormone receptor status. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15 .

BAŞARAN, G., Cabuk, D., Teomete, M., GÜLLÜOĞLU, M. B., KAYA, H., Dane, F., ... Yumuk, P. F.(2008). Benefit from adjuvant anthracyclines according to hormone receptor status. JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.

BAŞARAN, Gül Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status," JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008

BAŞARAN, Gül Et Al. "Benefit from adjuvant anthracyclines according to hormone receptor status." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15, 2008

BAŞARAN, G. Et Al. (2008) . "Benefit from adjuvant anthracyclines according to hormone receptor status." JOURNAL OF CLINICAL ONCOLOGY , vol.26, no.15.

@article{article, author={Gül BAŞARAN Et Al. }, title={Benefit from adjuvant anthracyclines according to hormone receptor status}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2008}